BACKGROUND AND PURPOSE: In patients with multiple sclerosis (MS), reduced magnetization transfer ratios (MTRs) have been reported in white matter that appears normal on studies obtained with conventional imaging techniques. The stage in the disease when this first becomes detectable is unclear. The purpose of this study was to measure the MTR of normal-appearing white matter (NAWM) and lesions in patients with clinically isolated syndromes (CIS), many of whom are at the earliest stages of MS, and to determine the prognostic value of any observed changes. METHODS: Twenty-seven CIS patients and 13 matched control subjects were studied. The mean MTR was measured from 10 regions of NAWM and, when present, from lesions. The patients were followed-up clinically for a median of 12 months. RESULTS: There was no significant difference in the mean MTR between NAWM in control subjects (38.5% units) and that in CIS patients (38.4% units). After 12 months' follow-up, MS developed in 26% of the patients. The MTR of NAWM in these patients did not differ from that of the other patients or the control subjects. CONCLUSION: The reduced MTR in NAWM, described in established MS, was not detectable in patients with CIS. MTR did not provide prognostic information for this short period of follow-up.
BACKGROUND AND PURPOSE: In patients with multiple sclerosis (MS), reduced magnetization transfer ratios (MTRs) have been reported in white matter that appears normal on studies obtained with conventional imaging techniques. The stage in the disease when this first becomes detectable is unclear. The purpose of this study was to measure the MTR of normal-appearing white matter (NAWM) and lesions in patients with clinically isolated syndromes (CIS), many of whom are at the earliest stages of MS, and to determine the prognostic value of any observed changes. METHODS: Twenty-seven CIS patients and 13 matched control subjects were studied. The mean MTR was measured from 10 regions of NAWM and, when present, from lesions. The patients were followed-up clinically for a median of 12 months. RESULTS: There was no significant difference in the mean MTR between NAWM in control subjects (38.5% units) and that in CIS patients (38.4% units). After 12 months' follow-up, MS developed in 26% of the patients. The MTR of NAWM in these patients did not differ from that of the other patients or the control subjects. CONCLUSION: The reduced MTR in NAWM, described in established MS, was not detectable in patients with CIS. MTR did not provide prognostic information for this short period of follow-up.
Authors: J I O'Riordan; A J Thompson; D P Kingsley; D G MacManus; B E Kendall; P Rudge; W I McDonald; D H Miller Journal: Brain Date: 1998-03 Impact factor: 13.501
Authors: I E Ormerod; D H Miller; W I McDonald; E P du Boulay; P Rudge; B E Kendall; I F Moseley; G Johnson; P S Tofts; A M Halliday Journal: Brain Date: 1987-12 Impact factor: 13.501
Authors: M A van Buchem; R I Grossman; C Armstrong; M Polansky; Y Miki; F H Heyning; M P Boncoeur-Martel; L Wei; J K Udupa; M Grossman; D L Kolson; J C McGowan Journal: Neurology Date: 1998-06 Impact factor: 9.910
Authors: M D Phillips; R I Grossman; Y Miki; L Wei; D L Kolson; M A van Buchem; M Polansky; J C McGowan; J K Udupa Journal: AJNR Am J Neuroradiol Date: 1998 Jun-Jul Impact factor: 3.825
Authors: J H van Waesberghe; W Kamphorst; C J De Groot; M A van Walderveen; J A Castelijns; R Ravid; G J Lycklama à Nijeholt; P van der Valk; C H Polman; A J Thompson; F Barkhof Journal: Ann Neurol Date: 1999-11 Impact factor: 10.422
Authors: Bertrand Audoin; My Van Au Duong; Jean-Philippe Ranjeva; Danielle Ibarrola; Irina Malikova; Sylviane Confort-Gouny; Elisabeth Soulier; Patrick Viout; André Ali-Chérif; Jean Pelletier; Patrick J Cozzone Journal: Hum Brain Mapp Date: 2005-03 Impact factor: 5.038
Authors: Wenna Duan; Parshant Sehrawat; Tony D Zhou; James T Becker; Oscar L Lopez; H Michael Gach; Weiying Dai Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160
Authors: Andrew W Varga; Glyn Johnson; James S Babb; Joseph Herbert; Robert I Grossman; Matilde Inglese Journal: J Neurol Sci Date: 2009-01-31 Impact factor: 3.181
Authors: C M Dalton; P A Brex; R Jenkins; N C Fox; K A Miszkiel; W R Crum; J I O'Riordan; G T Plant; A J Thompson; D H Miller Journal: J Neurol Neurosurg Psychiatry Date: 2002-08 Impact factor: 10.154